An international survey finds one-third of pharmaceutical companies have moved AI into live clinical trial operations, but fewer than one in three say the technology is meeting expectations.
An international survey finds one-third of pharmaceutical companies have moved AI into live clinical trial operations, but fewer than one in three say the technology is meeting expectations.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.